Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Di Giorgio FP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Francesco Paolo Di Giorgio, Andrea Ballabio, Mariangela Iovino, Gilda Cobellis, Massimo Zollo, Manlio Barbarisi, Marco Sardiello, Riccardo Cortese, Emanuele Marra, Antonio Romito, Nicola Iovino, Giancarlo Nicolaus
Publikováno v:
Nucleic Acids Research
Scopus-Elsevier
Scopus-Elsevier
In an effort to make transgenesis more flexible and reproducible, we developed a system based on novel 5′ and 3′ 'gene trap' vectors containing heterospecific Flp recognition target sites and the corresponding 'exchange' vectors allowing the inse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca548e9c073fc056c3617f5ad151c89
http://hdl.handle.net/11588/100169
http://hdl.handle.net/11588/100169
Autor:
Alberto M. Martelli, Michela Aluigi, Lucia Manzoli, Daniela Peruzzi, Lucio Cocco, Francesco Paolo Di Giorgio, Manuela Morleo, Anna Maria Billi
Publikováno v:
Biochimica et biophysica acta. 1584(1)
Inositide-specific phospholipase C (PLC) signaling constitutes a central intermediate in a number of cellular functions among which the control of cell growth raises a particular interest. Indeed, we have previously shown that nuclear phospholipase C
Autor:
Oggianu L; Angelini Pharma S.p.A., Rome, Italy., Garrone B; Angelini Pharma S.p.A., Rome, Italy., Fiorentini F; Accelera S.r.l., Milan, Italy., Del Bene F; Accelera S.r.l., Milan, Italy.; Parexel International, Milan, Italy., Rosignoli MT; Angelini Pharma S.p.A., Rome, Italy., Di Giorgio FP; Angelini Pharma S.p.A., Rome, Italy., Kaminski RM; Angelini Pharma S.p.A., Rome, Italy.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2023 Apr; Vol. 16 (4), pp. 606-617. Date of Electronic Publication: 2023 Feb 13.
Autor:
Porceddu PF; D3 Validation Research Line, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy., Ciampoli M; D3 Validation Research Line, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy., Romeo E; D3 Validation Research Line, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy., Garrone B; Angelini Pharma S.p.A., Viale Amelia 70, 00181 Rome, Italy., Durando L; Angelini Pharma S.p.A., Viale Amelia 70, 00181 Rome, Italy., Milanese C; Angelini Pharma S.p.A., Viale Amelia 70, 00181 Rome, Italy., Di Giorgio FP; Angelini Pharma S.p.A., Viale Amelia 70, 00181 Rome, Italy., Reggiani A; D3 Validation Research Line, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2022 Mar 21; Vol. 31 (6), pp. 839-849.
Autor:
Garofalo B; Angelini Pharma S.p.A., Rome, Italy., Bonvin AMJJ; Faculty of Science-Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, Netherlands., Bosin A; Department of Physics, University of Cagliari, Cagliari, Italy., Di Giorgio FP; Angelini Pharma S.p.A., Rome, Italy., Ombrato R; Angelini Pharma S.p.A., Rome, Italy., Vargiu AV; Department of Physics, University of Cagliari, Cagliari, Italy.
Publikováno v:
Frontiers in molecular biosciences [Front Mol Biosci] 2022 Mar 03; Vol. 9, pp. 839249. Date of Electronic Publication: 2022 Mar 03 (Print Publication: 2022).
Autor:
Westmark PR; Department of Neurology, University of Wisconsin, Madison, WI, United States., Garrone B; Angelini Pharma S.p.A., Rome, Italy., Ombrato R; Angelini Pharma S.p.A., Rome, Italy., Milanese C; Angelini Pharma S.p.A., Rome, Italy., Di Giorgio FP; Angelini Pharma S.p.A., Rome, Italy., Westmark CJ; Department of Neurology, University of Wisconsin, Madison, WI, United States.; Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, WI, United States.
Publikováno v:
Frontiers in molecular neuroscience [Front Mol Neurosci] 2021 Oct 07; Vol. 14, pp. 751307. Date of Electronic Publication: 2021 Oct 07 (Print Publication: 2021).
Autor:
Garofalo B; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy., Prati F; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy., Buonfiglio R; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy., Coletta I; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy., D'Atanasio N; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy., Molteni A; Axxam SpA Via Meucci 3, Bresso, 20091 Milan, Italy., Carettoni D; Axxam SpA Via Meucci 3, Bresso, 20091 Milan, Italy., Wanke V; Axxam SpA Via Meucci 3, Bresso, 20091 Milan, Italy., Pochetti G; Consiglio Nazionale delle Ricerche-Istituto di Cristallografia, Via Salaria-km 29.300, Monterotondo, 00015 Rome, Italy., Montanari R; Consiglio Nazionale delle Ricerche-Istituto di Cristallografia, Via Salaria-km 29.300, Monterotondo, 00015 Rome, Italy., Capelli D; Consiglio Nazionale delle Ricerche-Istituto di Cristallografia, Via Salaria-km 29.300, Monterotondo, 00015 Rome, Italy., Milanese C; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy., Di Giorgio FP; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy., Ombrato R; Angelini Pharma S.p.A., Global R&D External Innovation, Viale Amelia 70, 00181 Rome, Italy.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Jun 25; Vol. 14 (7). Date of Electronic Publication: 2021 Jun 25.
Autor:
Garrone B; Angelini Pharma S.p.A., Viale Amelia, 70, 00181, Rome, Italy., Durando L; Angelini Pharma S.p.A., Viale Amelia, 70, 00181, Rome, Italy., Prenderville J; Transpharmation Ireland Ltd., Trinity College Dublin-Institute of Neuroscience (TCIN), Lloyd Institute, Trinity College, Dublin 2, Ireland., Sokolowska E; Transpharmation Ireland Ltd., Trinity College Dublin-Institute of Neuroscience (TCIN), Lloyd Institute, Trinity College, Dublin 2, Ireland., Milanese C; Angelini Pharma S.p.A., Viale Amelia, 70, 00181, Rome, Italy., Di Giorgio FP; Angelini Pharma S.p.A., Viale Amelia, 70, 00181, Rome, Italy., Callaghan C; Ulysses Neuroscience Ltd, Room 3.57B, Trinity College Dublin-Institute of Neuroscience (TCIN), Lloyd Institute, Trinity College, Dublin 2, Ireland., Bianchi M; Ulysses Neuroscience Ltd, Room 3.57B, Trinity College Dublin-Institute of Neuroscience (TCIN), Lloyd Institute, Trinity College, Dublin 2, Ireland. max.bianchi@ulysses-neuro.com.
Publikováno v:
Scientific reports [Sci Rep] 2021 May 12; Vol. 11 (1), pp. 10139. Date of Electronic Publication: 2021 May 12.